Qi LS - Search Results

1

The value of AGR2 and KRT5 as an immunomarker combination in distinguishing lung squamous cell carcinoma from adenocarcinoma.

Pan B, Wei ZX, Zhang JX, Li X, Meng QW, Cao YY, Qi LS, Yu Y. Pan B, et al. Among authors: qi ls. Am J Transl Res. 2021 May 15;13(5):4464-4476. eCollection 2021. Am J Transl Res. 2021. PMID: 34150027 Free PMC article.

2

An individualized gene expression signature for prediction of lung adenocarcinoma metastases.

Qi L, Li T, Shi G, Wang J, Li X, Zhang S, Chen L, Qin Y, Gu Y, Zhao W, Guo Z. Qi L, et al. Mol Oncol. 2017 Nov;11(11):1630-1645. doi: 10.1002/1878-0261.12137. Epub 2017 Oct 10. Mol Oncol. 2017. PMID: 28922552 Free PMC article.

3

A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy.

Liu Y, Zhang Z, Li T, Li X, Zhang S, Li Y, Zhao W, Gu Y, Guo Z, Qi L. Liu Y, et al. Front Oncol. 2019 Oct 18;9:1094. doi: 10.3389/fonc.2019.01094. eCollection 2019. Front Oncol. 2019. PMID: 31681618 Free PMC article.

4

A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas.

Li X, Shi G, Chu Q, Jiang W, Liu Y, Zhang S, Zhang Z, Wei Z, He F, Guo Z, Qi L. Li X, et al. BMC Genomics. 2019 Nov 21;20(1):881. doi: 10.1186/s12864-019-6086-2. BMC Genomics. 2019. PMID: 31752667 Free PMC article.

5

Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma.

Li Y, Jiang W, Li T, Li M, Li X, Zhang Z, Zhang S, Liu Y, Zhao W, Gu Y, Qi L, Ao L, Guo Z. Li Y, et al. J Transl Med. 2020 Jan 14;18(1):25. doi: 10.1186/s12967-019-02199-6. J Transl Med. 2020. PMID: 31937321 Free PMC article.

6

Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma.

Zhang Z, Zhang S, Li X, Zhao Z, Chen C, Zhang J, Li M, Wei Z, Jiang W, Pan B, Li Y, Liu Y, Cao Y, Zhao W, Gu Y, Yu Y, Meng Q, Qi L. Zhang Z, et al. Brief Bioinform. 2021 May 20;22(3):bbaa081. doi: 10.1093/bib/bbaa081. Brief Bioinform. 2021. PMID: 32383445

7

RNA-binding motif protein 10 represses tumor progression through the Wnt/β- catenin pathway in lung adenocarcinoma.

Cao Y, Geng J, Wang X, Meng Q, Xu S, Lang Y, Zhou Y, Qi L, Wang Z, Wei Z, Yu Y, Jin S, Pan B. Cao Y, et al. Int J Biol Sci. 2022 Jan 1;18(1):124-139. doi: 10.7150/ijbs.63598. eCollection 2022. Int J Biol Sci. 2022. PMID: 34975322 Free PMC article.

8

Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis.

Li X, Tang L, Deng J, Qi X, Zhang J, Qi H, Li M, Liu Y, Zhao W, Gu Y, Qi L, Li X. Li X, et al. Commun Biol. 2022 Mar 17;5(1):198. doi: 10.1038/s42003-022-03135-z. Commun Biol. 2022. PMID: 35301413 Free PMC article.

9

Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors.

Zhang J, Deng J, Feng X, Tan Y, Li X, Liu Y, Li M, Qi H, Tang L, Meng Q, Yan H, Qi L. Zhang J, et al. Front Genet. 2022 Aug 29;13:944167. doi: 10.3389/fgene.2022.944167. eCollection 2022. Front Genet. 2022. PMID: 36105102 Free PMC article.

10

Identification of mutational signature for lung adenocarcinoma prognosis and immunotherapy prediction.

Zhang S, Li M, Tan Y, Zhang J, Liu Y, Jiang W, Li X, Qi H, Tang L, Ji R, Zhao W, Gu Y, Qi L. Zhang S, et al. J Mol Med (Berl). 2022 Dec;100(12):1755-1769. doi: 10.1007/s00109-022-02266-4. Epub 2022 Nov 11. J Mol Med (Berl). 2022. PMID: 36367565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters